Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biliary Atresia | 2 | 2020 | 201 | 0.970 |
Why?
|
| Liver Transplantation | 4 | 2021 | 1184 | 0.820 |
Why?
|
| Portoenterostomy, Hepatic | 2 | 2020 | 49 | 0.650 |
Why?
|
| Microbiota | 1 | 2020 | 545 | 0.460 |
Why?
|
| End Stage Liver Disease | 1 | 2014 | 186 | 0.400 |
Why?
|
| Cholangitis, Sclerosing | 2 | 2024 | 84 | 0.400 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 2 | 2021 | 24 | 0.360 |
Why?
|
| Cholestasis | 2 | 2022 | 206 | 0.350 |
Why?
|
| Purpura | 2 | 2021 | 35 | 0.350 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 605 | 0.330 |
Why?
|
| Clostridium Infections | 2 | 2021 | 261 | 0.260 |
Why?
|
| Bile Acids and Salts | 2 | 2022 | 261 | 0.210 |
Why?
|
| Alagille Syndrome | 1 | 2022 | 48 | 0.200 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2024 | 356 | 0.200 |
Why?
|
| Disease Resistance | 1 | 2021 | 25 | 0.200 |
Why?
|
| Vancomycin | 1 | 2024 | 292 | 0.200 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 2022 | 71 | 0.200 |
Why?
|
| Hypertension, Portal | 1 | 2021 | 129 | 0.180 |
Why?
|
| Bile | 1 | 2020 | 85 | 0.180 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2022 | 186 | 0.170 |
Why?
|
| Organoids | 1 | 2021 | 327 | 0.160 |
Why?
|
| Infant | 5 | 2022 | 13936 | 0.150 |
Why?
|
| Liver Diseases | 1 | 2022 | 605 | 0.140 |
Why?
|
| Graft Rejection | 1 | 2021 | 865 | 0.140 |
Why?
|
| Intestines | 1 | 2021 | 740 | 0.140 |
Why?
|
| Stem Cells | 1 | 2021 | 1236 | 0.120 |
Why?
|
| Biomarkers | 3 | 2022 | 5114 | 0.110 |
Why?
|
| Stroke | 1 | 2021 | 1094 | 0.100 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 968 | 0.100 |
Why?
|
| Waiting Lists | 1 | 2014 | 265 | 0.100 |
Why?
|
| Endoscopy, Digestive System | 1 | 2013 | 210 | 0.100 |
Why?
|
| Time-to-Treatment | 1 | 2014 | 312 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 3176 | 0.090 |
Why?
|
| Abdominal Pain | 1 | 2013 | 379 | 0.090 |
Why?
|
| Cell Differentiation | 1 | 2021 | 4195 | 0.090 |
Why?
|
| Tissue Donors | 1 | 2014 | 812 | 0.090 |
Why?
|
| Age Factors | 2 | 2021 | 5521 | 0.090 |
Why?
|
| Budesonide | 1 | 2009 | 35 | 0.090 |
Why?
|
| Eosinophils | 1 | 2009 | 168 | 0.080 |
Why?
|
| Gastrointestinal Diseases | 1 | 2013 | 617 | 0.080 |
Why?
|
| Cytokines | 1 | 2017 | 2841 | 0.080 |
Why?
|
| Sinusitis | 1 | 2009 | 148 | 0.080 |
Why?
|
| Interleukin-8 | 2 | 2022 | 531 | 0.080 |
Why?
|
| Brain | 1 | 2021 | 4252 | 0.070 |
Why?
|
| Eosinophilia | 1 | 2009 | 188 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 7929 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 460 | 0.070 |
Why?
|
| Child | 6 | 2024 | 30499 | 0.060 |
Why?
|
| Humans | 12 | 2024 | 271941 | 0.060 |
Why?
|
| Treatment Outcome | 4 | 2024 | 33874 | 0.060 |
Why?
|
| Adolescent | 5 | 2024 | 32687 | 0.050 |
Why?
|
| Endoglin | 1 | 2022 | 41 | 0.050 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2022 | 33 | 0.050 |
Why?
|
| Butyrates | 1 | 2022 | 58 | 0.050 |
Why?
|
| Risk Factors | 2 | 2021 | 18047 | 0.050 |
Why?
|
| Pruritus | 1 | 2022 | 87 | 0.050 |
Why?
|
| Liver | 2 | 2022 | 3124 | 0.050 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2021 | 55 | 0.050 |
Why?
|
| Enterohepatic Circulation | 1 | 2021 | 10 | 0.050 |
Why?
|
| Aspartate Aminotransferases | 1 | 2021 | 148 | 0.050 |
Why?
|
| Benzodiazepines | 1 | 2022 | 174 | 0.050 |
Why?
|
| Alanine Transaminase | 1 | 2021 | 240 | 0.050 |
Why?
|
| Time | 1 | 2021 | 186 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2024 | 4399 | 0.040 |
Why?
|
| Internationality | 1 | 2021 | 206 | 0.040 |
Why?
|
| Drug Resistance | 1 | 2021 | 615 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2024 | 1620 | 0.040 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2019 | 22 | 0.040 |
Why?
|
| Consanguinity | 1 | 2019 | 116 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2022 | 17006 | 0.040 |
Why?
|
| Stomach | 1 | 2021 | 405 | 0.040 |
Why?
|
| Graft Survival | 1 | 2021 | 1092 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2021 | 620 | 0.040 |
Why?
|
| Remission Induction | 1 | 2024 | 3645 | 0.040 |
Why?
|
| Interleukin-5 | 1 | 2017 | 69 | 0.040 |
Why?
|
| Glucosyltransferases | 1 | 2017 | 55 | 0.040 |
Why?
|
| Mitochondrial Proteins | 1 | 2019 | 385 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2017 | 257 | 0.030 |
Why?
|
| Liver Cirrhosis | 1 | 2022 | 1033 | 0.030 |
Why?
|
| Registries | 1 | 2021 | 2252 | 0.030 |
Why?
|
| Male | 5 | 2024 | 128995 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2017 | 1180 | 0.030 |
Why?
|
| Recurrence | 1 | 2021 | 4887 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2021 | 5788 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2017 | 1066 | 0.030 |
Why?
|
| Female | 5 | 2024 | 149187 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2021 | 5841 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 4891 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2024 | 9494 | 0.020 |
Why?
|
| Disease Progression | 1 | 2021 | 6910 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2009 | 299 | 0.020 |
Why?
|
| Time Factors | 1 | 2021 | 13130 | 0.020 |
Why?
|
| Phenotype | 1 | 2019 | 6516 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2009 | 1853 | 0.010 |
Why?
|
| Helicobacter pylori | 1 | 2013 | 1434 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2009 | 2866 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2024 | 39800 | 0.010 |
Why?
|
| Mice | 1 | 2021 | 36054 | 0.010 |
Why?
|
| Prognosis | 1 | 2017 | 22550 | 0.010 |
Why?
|
| Mutation | 1 | 2019 | 15941 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2013 | 13402 | 0.010 |
Why?
|
| Animals | 1 | 2021 | 62823 | 0.010 |
Why?
|
| United States | 1 | 2013 | 16053 | 0.010 |
Why?
|